In the present study, a combined HPV16 L1 gene methylation (≥20%) and a low percentage of a CD4 count might be beneficial to differentiate HIV-infected MSM who are at risk to rapidly progress to high-grade AIN and carcinoma. The gene discussed is CD4; the disease is carcinoma.